TW197436B - - Google Patents

Info

Publication number
TW197436B
TW197436B TW081102005A TW81102005A TW197436B TW 197436 B TW197436 B TW 197436B TW 081102005 A TW081102005 A TW 081102005A TW 81102005 A TW81102005 A TW 81102005A TW 197436 B TW197436 B TW 197436B
Authority
TW
Taiwan
Application number
TW081102005A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of TW197436B publication Critical patent/TW197436B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
TW081102005A 1991-04-26 1992-03-17 TW197436B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26

Publications (1)

Publication Number Publication Date
TW197436B true TW197436B (zh) 1993-01-01

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081102005A TW197436B (zh) 1991-04-26 1992-03-17

Country Status (20)

Country Link
EP (1) EP0590094A1 (zh)
JP (1) JPH0776215B2 (zh)
CN (1) CN1066068A (zh)
AU (1) AU1879792A (zh)
BR (1) BR9205939A (zh)
CA (1) CA2108014A1 (zh)
CZ (1) CZ395592A3 (zh)
DE (1) DE9290049U1 (zh)
FI (1) FI934710A (zh)
HU (1) HUT65748A (zh)
IE (1) IE921330A1 (zh)
IL (1) IL101627A0 (zh)
MX (1) MX9201916A (zh)
NO (1) NO933837L (zh)
NZ (1) NZ242493A (zh)
PT (1) PT100426A (zh)
TW (1) TW197436B (zh)
WO (1) WO1992019614A1 (zh)
YU (1) YU44592A (zh)
ZA (1) ZA922976B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE175196T1 (de) * 1992-01-23 1999-01-15 Pfizer 4-phenyl-3-(heteroarylureido)-1,2-dihydro-2- oxochinolin derivate, als antihypercholesterolemische und antiatherosklerotische mittel
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
CA2222687A1 (en) * 1995-05-31 1996-12-05 Masami Muraoka Novel naphthyridine derivatives
CA2272068A1 (en) * 1996-11-26 1998-06-04 Masami Muraoka Novel naphthyridine derivatives
WO1999043659A1 (fr) 1998-02-25 1999-09-02 Sumitomo Pharmaceuticals Co., Ltd. Derives de pyridone et leur procede de fabrication
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
WO2005058834A2 (en) * 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
CN103601677B (zh) * 2013-11-19 2015-11-18 清华大学 制备2-烷硫基喹啉衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (zh) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
NO933837L (no) 1993-10-25
FI934710A0 (fi) 1993-10-25
BR9205939A (pt) 1994-09-27
JPH06501025A (ja) 1994-01-27
HU9303025D0 (en) 1994-01-28
AU1879792A (en) 1992-12-21
HUT65748A (en) 1994-07-28
ZA922976B (en) 1993-10-25
WO1992019614A1 (en) 1992-11-12
DE9290049U1 (de) 1994-01-05
MX9201916A (es) 1992-11-01
NZ242493A (en) 1994-08-26
JPH0776215B2 (ja) 1995-08-16
CZ395592A3 (en) 1994-02-16
EP0590094A1 (en) 1994-04-06
PT100426A (pt) 1993-08-31
CA2108014A1 (en) 1992-10-27
IE921330A1 (en) 1992-11-04
CN1066068A (zh) 1992-11-11
IL101627A0 (en) 1992-12-30
YU44592A (sh) 1994-12-28
FI934710A (fi) 1993-10-25

Similar Documents

Publication Publication Date Title
DE9103022U1 (zh)
DE9102855U1 (zh)
DE9101734U1 (zh)
DE9104672U1 (zh)
DE9105431U1 (zh)
DE4292274T1 (zh)
DE9100715U1 (zh)
DE9100911U1 (zh)
DE9100281U1 (zh)
DE9100998U1 (zh)
DE9103169U1 (zh)
DE9101777U1 (zh)
DE9103606U1 (zh)
DE9105090U1 (zh)
DE9102640U1 (zh)
DE9104787U1 (zh)
DE9100452U1 (zh)
DE9105384U1 (zh)
DE9102244U1 (zh)
DE9100767U1 (zh)
DE9102568U1 (zh)
DE9104694U1 (zh)
DE9101796U1 (zh)
DE9100579U1 (zh)
DE9101258U1 (zh)